Adverse Event Data Could Tip Scales In Cosmetics Regulatory Reform
This article was originally published in The Rose Sheet
Executive Summary
FDA publishes data on AERs from January 2004 through September 2016 for food – including food additives and color additives – dietary supplements and cosmetics.
You may also be interested in...
Former FDA Commish Califf Advocates Cosmetics Registration, AE Reporting
FDA is hampered in its public safety mission under current law, which does not require cosmetics firms to register marketed products or report adverse events, former agency head Robert Califf says. His June 26 editorial in Jama Internal Medicine accompanies an analysis of FDA's cosmetics adverse-event data.
FDA Divulges Cosmetics Enforcement Data, Notes Hair Loss As ‘Serious’ AE
Momentum this year behind legislative proposals for cosmetics regulatory reform has prompted key Congress members to question FDA about the current oversight system. In a response to the Senate HELP Committee’s chairman, FDA provides a wealth of data on its enforcement activities and confirms hair loss as an adverse event it considers “serious,” if not one currently identified as such by MedWatch’s definition.
Mandatory AE Reporting In Supplement Space Offers Glimpse Of Possible Cosmetic Future
Reports of serious adverse events in the dietary supplement industry have increased exponentially since reporting was made mandatory in 2008, and FDA warning letters citing failures to report have been on the rise as companies labor to keep up with investigations and reporting duties. Similar challenges could lie ahead for the cosmetics industry under proposed bills in the US House and Senate.